Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma

Molecular and Cellular Biology

Volumn 16, Issue 7, 1996, Pages 3844-3852

  Parry, David ^a   Peters, Gordon ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYCLIN DEPENDENT KINASE; DNA; METHIONINE; RETINOBLASTOMA PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CHROMOSOME 9P; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FAMILIAL CANCER; MELANOMA; MISSENSE MUTATION; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; TEMPERATURE SENSITIVE MUTANT; TUMOR SUPPRESSOR GENE;

BONE NEOPLASMS; CARRIER PROTEINS; CELL LINE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; GENES, TUMOR SUPPRESSOR; HUMANS; MELANOMA; MUTAGENESIS, SITE-DIRECTED; MUTATION; OSTEOSARCOMA; POINT MUTATION; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; SEQUENCE DELETION; TEMPERATURE; TRANSFECTION; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

EID: 0029980941     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.7.3844     Document Type: Article

References (64)

1. Bonetta, L. 1994. Open questions on p16. Nature (London) 370:180.
2. Cairns, P., L. Mao, A. Merlo, D. J. Lee, D. Schwab, Y. Eby, K. Tokino, P. van der Riet, J. E. Blaugrund, and D. Sidransky. 1994. Rates of p16(MTS1) mutations in primary tumors with 9p loss. Science 265:415-416.
3. Caldas, C., S. A. Hahn, L. T. da Costa, M. S. Redston, M. Schutte, A. B. Seymour, C. L. Weinstein, R. H. Hruban, C. J. Yeo, and S. E. Kern. 1994. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomas. Nature Genet. 8:27-32.
4. Cannon-Albright, L. A., D. E. Goldgar, L. J. Meyer, C. M. Lewis, D. E. Anderson, J. W. Fountain, M. E. Hegi, R. W. Wiseman, E. M. Petty, A. E. Bale, O. Olopade, M. O. Diaz, D. J. Kwiatkowski, M. W. Piepkorn, J. J. Zone, and M. H. Skolnick. 1992. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258:1148-1152.
5. INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 11:21-29.
6. CDKN2/INK4A. Curr. Biol. 6:84-91.
7. Fantl, V., R. Smith, S. Brookes, C. Dickson, and G. Peters. 1993. Chromosome 11q13 abnormalities in human breast cancer. Cancer Surveys 18:77-94.
8. Giebel, L. B., R. K. Tripathi, R. A. King, and R. A. Spritz. 1991. A tyrosinase gene missense mutation in temperature-sensitive type 1 oculocutancous albinism. J. Clin. Invest. 87:1119-1122.
9. Goldstein, A. M., N. C. Dracopoli, M. Engelstein, M. C. Fraser, W. H. Clark, Jr., and M. A. Tucker. 1994. Linkage of cutaneous malignant melanoma/ dysplastic nevi to chromosome 9p. and evidence for genetic heterogeneity. Am. J. Hum. Genet. 54:489-496.
10. CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55:4531-4535.
11. Gruis, N. A., P. A. van der Velden, L. A. Sandkuiji, D. E. Prins, J. Weaver-Feldhaus, A. Kamb, W. Bergman, and R. R. Frants. 1995. Homozygotes for CDKN2 (p16) germline mutations in Dutch familial melanoma kindreds. Nature Genet. 10:351-353.
12. INK4/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8:2939-2952.
13. Hall, M., S. Bates, and G. Peters. 1995. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11:1581-1588.
14. Hall, M., and G. Peters. 1996. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68:67-108.
15. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (London) 371:257-261.
16. CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16:859-867.
17. Hayashi, N., Y. Sugimoto, E. Tsuchiya, M. Ogawa, and Y. Nakamura. 1994. Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4I (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas. Biochem. Biophys. Res. Commun. 202:1426-1430.
18. INK4B) display frequent homozygous deletions in primary cells from T- but not B-cell lineage acute lymphoblastic leukemias. Blood 84:4038-4044.
19. Herman, J. G., A. Merlo, L. Mao, R. G. Lapidus, J.-P. J. Issa, N. E. Davidson, D. Sidransky, and S. B. Baylin. 1995. Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:4525-4530.
20. Hussussian, C. J., J. P. Struewing, A. M. Goldstein, P. A. T. Higgins, D. S. Ally, M. D. Sheahan, W. H. Clark, Jr., M. A. Tucker, and N. C. Dracopoli. 1994. Germline p16 mutations in familial melanoma. Nature Genet. 8:15-21.
21. Jen, J., J. W. Harper, S. H. Bigner, D. D. Bigner, N. Papadopoulos, S. Markowitz, J. K. V. Willson, K. W. Kinzler, and B. Vogelstein. 1994. Deletion of p16 and p15 genes in brain tumors. Cancer Res. 54:6353-6358.
22. Kamb, A., N. A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V. Tavtiglan, E. Stockert, R. S. Day III, B. E. Johnson, and M. H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
23. Kamb, A., D. Shattuck-Eidens, R. Eeles, Q. Liu, N. A. Gruis, W. Ding, C. Hussey, T. Tran, Y. Miki, J. Weaver-Feldhaus, M. McClure, J. F. Aitken, D. E. Anderson, W. Bergman, R. Frants, D. E. Goldgar, A. Green, R. MacLennan, N. G. Martin, L. J. Meyer, P. Youl, J. J. Zone, M. H. Skolnick, and L. A. Cannon-Albright. 1994. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8:22-26.
24. Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331-342.
25. Khatib, Z. A., H. Matsushime, M. Valentine, D. N. Shapiro, C. J. Sherr, and A. T. Look. 1993. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res. 53:5535-5541.
26. King, R. A., D. Townsend, W. Oetting, C. G. Summers, D. P. Olds, J. G. White, and R. A. Spritz. 1991. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism. J. Clin. Invest. 87:1046-1053.
27. Koh, J., G. H. Enders, B. D. Dynlacht, and E. Harlow. 1995. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (London) 375:506-510.
28. Liu, Q., S. Neuhausen, M. McClure, C. Frye, J. Weaver-Feldhaus, N. A. Gruis, K. Eddington, M. J. Allalunis-Turner, M. H. Skolnick, F. K. Fujimura, and A. Kamb. 1995. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 10:1061-1067.
29. Loughran, O., K. G. Edington, I. J. Berry, L. J. Clark, and E. K. Parkinson. 1994. Loss of heterozygosity of chromosome 9p21 is associated with the immortal phenotype of neoplastic human head and neck keratinocytes. Cancer Res. 54:5045-5049.
30. Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Barlek. 1995. Retinoblastoma-protein-dependent cell cycle inhibition by the tumour suppressor p16. Nature (London) 375:503-506.
31. INK4A transcript. Cancer Res. 55:2995-2997.
32. Marx, J. 1994. A challenge to the p16 gene as a major tumor suppressor. Science 264:1846.
33. Merlo, A., J. G. Herman, L. Mao, D. J. Lee, E. Gabrielson, P. C. Burger, S. B. Baylin, and D. Sidransky. 1995. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1:686-692.
34. Mori, T., K. Miura, T. Aoki, T. Nishihira, S. Mori, and Y. Nakamura. 1994. Frequent somatic mutations of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 54:3396-3397.
35. Moulton, T., G. Samara, W.-Y. Chung, L. Yuan, R. Desai, M. Sisti, J. Bruce, and B. Tycko. 1995. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. Am. J. Pathol. 146:613-619.
36. Nancarrow, D. J., G. J. Mann, E. A. Holland, G. J. Walker, S. C. Beaton. M. K. Walters, C. Luxford, J. M. Palmer, J. A. Donald, J. L. Weber, J. W. Fountain, R. F. Kefford, and N. K. Hayward. 1993. Confirmation of chromosome 9p linkage in familial melanoma. Am. J. Hum. Genet. 53:936-942.
37. Nobori, T., K. Miura, D. J. Wu, A. Lois, K. Takabayashi, and D. A. Carson. 1994. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (London) 368:753-756.
38. Ohta, M., H. Nagai, M. Shimizu, D. Rasio, D. Berd, M. Mastrangelo, A. D. Singh, J. A. Shields, C. L. Shields, C. M. Croce, and K. Huebner. 1994 Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res. 54:5269-5272.
39. INK4 in human cancer. Proc. Natl. Acad. Sci. USA 91:11045-11049.
40. INK4 protein induction by 5-aza 2′ deoxycytidine. Oncogene 11:1211-1216.
41. INK4/MTS1 tumour suppressor gene product. EMBO J. 14:503-511.
42. Pollock, P. M., F. Yu, L. Qiu, P. G. Parson, and N. K. Hayward. 1995. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines. Oncogene 11:663-668.
43. INK4b genes. Oncogene 11:635-645.
44. Quelle, D. E., F. Zindy, R. A. Ashmun, and C. J. Sherr. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
45. INK4 function. Nature Genet. 10:114-116.
46. Reymond, A., and R. Brent. 1995. p16 proteins from melanoma-prone families are deficient in binding to Cdk4. Oncogenc 11:1173-1178.
47. INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol. Cell. Biol. 15:4745-4753.
48. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (London) 366:704-707.
49. Serrano, M., H.-W. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R. A. DePinho. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-37.
50. Sheaff, R. J., and J. M. Roberts. 1995. Lessons in p16 from phylum Falconium. Curr. Biol. 5:28-31.
51. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
52. Spruck, C. H., III, M. Gonzales-Zulueta, A. Shibata, A. R. Simoneau, M.-F. Lin, F. Gonzales, Y. C. Tsai, and P. A. Jones. 1994. p16 gene in uncultured tumours. Nature (London) 370:183-184.
53. Stone, S., P. Dayanath, P. Jiang, J. M. Weaver-Feldhaus, S. V. Tavtigian, L. Cannon-Albright, and A. Kamb. 1995. Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene 11:987-991.
54. Stone, S., P. Jiang, P. Dayanath, S. V. Tavtigian, H. Katcher, D. Parry, G. Peters, and A. Kamb. 1995. Complex structure and regulation of the P16 (MTS1) locus. Cancer Res. 55:2988-2994.
55. Suzuki, H., X. Zhou, J. Yin, J. Lei, H. Y. Jiang, Y. Suzuki, T. Chan, G. J. Hannon, W. J. Mergner, J. M. Abraham, and S. J. Meltzer. 1995. Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers. Hum. Mol. Genet. 4:1883-1887.
56. Ueki, K., M.-P. Rubio, V. Ramesh, K. M. Correa, J. L. Rutter, A. von-Deimling, A. J. Buckler, J. F. Gusella, and D. N. Louis. 1994. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum. Mol. Genet. 3:1841-1845.
57. van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2054.
58. INK4 gene in Australian melanoma kindreds. Hum. Mol. Genet. 4:1845-1852.
59. Wick, S. T., M. M. Dubay, I. Imanil, and L. Brizuela. 1995. Biochemical and mutagenic analysis of the melanoma tumor suppressor gene product/p16. Oncugene 11:2013-2019.
60. Ink4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269:1281-1284.
61. INK4a tumor suppressor protein. Cancer Res. 55:2503-2506.
62. Yeudall, W. A., R. Y. Crawford, J. F. Ensley, and K. C. Robbins. 1994 MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis 15:2683-2686.
63. Zhang, S.-Y., A. J. P. Klein-Szanto, E. R. Sauter, M. Shafarenko, S. Mitsunaga, T. Nobori, D. A. Carson, J. A. Ridge, and T. L. Goodrow. 1994. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res. 54:5050-5053.
64. INK4a binding domain of CDK4 in familial melanoma. Nature Genet. 12:97-99.